FGF21 regulates sweet and alcohol preference

Cell Metabolism

Volumn 23, Issue 2, 2016, Pages 344-349

  Talukdar, Saswata ^a,f   Owen, Bryn M ^b,g   Song, Parkyong ^b   Hernandez, Genaro ^b   Zhang, Yuan ^b   Zhou, Yingjiang ^a   Scott, William T ^b   Paratala, Bhavna ^a   Turner, Tod ^a   Smith, Andrew ^a   Bernardo, Barbara ^a   Müller, Christian P ^d,e   Tang, Hao ^c   Mangelsdorf, David J ^b,c   Goodwin, Bryan ^a   Kliewer, Steven A ^b,c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f MERCK RESEARCH LABORATORIES   (United States)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR 1; KLOTHO PROTEIN BETA; MESSENGER RNA; RECOMBINANT FIBROBLAST GROWTH FACTOR 23; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ALCOHOL DERIVATIVE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; SACCHARIN;

ALCOHOL CONSUMPTION; ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; MEDIAL PREFRONTAL CORTEX; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PUTAMEN; REWARD; SINGLE NUCLEOTIDE POLYMORPHISM; SUPRACHIASMATIC NUCLEUS; SWEETNESS; TASTE PREFERENCE; VENTRAL TEGMENTUM; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FOOD PREFERENCE; HAPLORHINI; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; TASTE;

ALCOHOLS; ANIMALS; CENTRAL NERVOUS SYSTEM; DOPAMINE; FIBROBLAST GROWTH FACTORS; FOOD PREFERENCES; HAPLORHINI; HUMANS; MALE; MICE, INBRED C57BL; SACCHARIN; SIGNAL TRANSDUCTION; TASTE;

EID: 84957949211     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.12.008     Document Type: Article

References (30)

1. M.K. Badman, P. Pissios, A.R. Kennedy, G. Koukos, J.S. Flier, and E. Maratos-Flier Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell Metab. 5 2007 426 437
2. A.L. Bookout, M.H. de Groot, B.M. Owen, S. Lee, L. Gautron, H.L. Lawrence, X. Ding, J.K. Elmquist, J.S. Takahashi, D.J. Mangelsdorf, and S.A. Kliewer FGF21 regulates metabolism and circadian behavior by acting on the nervous system Nat. Med. 19 2013 1147 1152
3. J.P. Camporez, F.R. Jornayvaz, M.C. Petersen, D. Pesta, B.A. Guigni, J. Serr, D. Zhang, M. Kahn, V.T. Samuel, M.J. Jurczak, and G.I. Shulman Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice Endocrinology 154 2013 3099 3109
4. A. Can, D.T. Dao, M. Arad, C.E. Terrillion, S.C. Piantadosi, and T.D. Gould The mouse forced swim test J. Vis. Exp. 59 2012 e3638
5. A. Can, D.T. Dao, C.E. Terrillion, S.C. Piantadosi, S. Bhat, and T.D. Gould The tail suspension test J. Vis. Exp. 59 2012 e3769
6. A.Y. Chu, T. Workalemahu, N.P. Paynter, L.M. Rose, F. Giulianini, T. Tanaka, J.S. Ngwa, Q. Qi, G.C. Curhan, E.B. Rimm, et al. CHARGE Nutrition Working Group DietGen Consortium Novel locus including FGF21 is associated with dietary macronutrient intake Hum. Mol. Genet. 22 2013 1895 1902
7. J.Q. Dong, M. Rossulek, V.R. Somayaji, D. Baltrukonis, Y. Liang, K. Hudson, M. Hernandez-Illas, and R.A. Calle Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study Br. J. Clin. Pharmacol. 80 2015 1051 1063
8. N. Douris, D.M. Stevanovic, F.M. Fisher, T.I. Cisu, M.J. Chee, N.L. Nguyen, E. Zarebidaki, A.C. Adams, A. Kharitonenkov, J.S. Flier, and et al. Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice Endocrinology 156 2015 2470 2481
9. J.R. Dushay, E. Toschi, E.K. Mitten, F.M. Fisher, M.A. Herman, and E. Maratos-Flier Fructose ingestion acutely stimulates circulating FGF21 levels in humans Mol. Metab. 4 2015 51 57
10. J.D. Fernstrom, S.D. Munger, A. Sclafani, I.E. de Araujo, A. Roberts, and S. Molinary Mechanisms for sweetness J. Nutr. 142 2012 1134S 1141S
11. Fraley, C., Raftery, A.E., Murphy, T.B., and Scrucca, L. (2012). mclust Version 4 for R: Normal Mixture Modeling for Model-Based Clustering, Classification, and Density Estimation. Technical Report No. 597, Department of Statistics, University of Washington. http://my.ilstu.edu/∼mxu2/mat456/mcluster.pdf.
12. R.E. Gimeno, and D.E. Moller FGF21-based pharmacotherapy - potential utility for metabolic disorders Trends Endocrinol. Metab. 25 2014 303 311
13. C. Giragossian, C. Vage, J. Li, K. Pelletier, N. Piché-Nicholas, M. Rajadhyaksha, J. Liras, A. Logan, R.A. Calle, and Y. Weng Mechanistic investigation of the preclinical pharmacokinetics and interspecies scaling of PF-05231023, a fibroblast growth factor 21-antibody protein conjugate Drug Metab. Dispos. 43 2015 803 811
14. R.A. Gonzales, M.O. Job, and W.M. Doyon The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement Pharmacol. Ther. 103 2004 121 146
15. H. Hsuchou, W. Pan, and A.J. Kastin The fasting polypeptide FGF21 can enter brain from blood Peptides 28 2007 2382 2386
16. J. Huang, T. Ishino, G. Chen, P. Rolzin, T.F. Osothprarop, K. Retting, L. Li, P. Jin, M.J. Matin, B. Huyghe, and et al. Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody J. Pharmacol. Exp. Ther. 346 2013 270 280
17. T. Inagaki, P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, V. Esser, and et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell Metab. 5 2007 415 425
18. V. Krishnan, M.H. Han, D.L. Graham, O. Berton, W. Renthal, S.J. Russo, Q. Laplant, A. Graham, M. Lutter, D.C. Lagace, and et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions Cell 131 2007 391 404
19. Q. Liang, L. Zhong, J. Zhang, Y. Wang, S.R. Bornstein, C.R. Triggle, H. Ding, K.S. Lam, and A. Xu FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting Diabetes 63 2014 4064 4075
20. B.M. Owen, A.L. Bookout, X. Ding, V.Y. Lin, S.D. Atkin, L. Gautron, S.A. Kliewer, and D.J. Mangelsdorf FGF21 contributes to neuroendocrine control of female reproduction Nat. Med. 19 2013 1153 1156
21. B.M. Owen, X. Ding, D.A. Morgan, K.C. Coate, A.L. Bookout, K. Rahmouni, S.A. Kliewer, and D.J. Mangelsdorf FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss Cell Metab. 20 2014 670 677
22. B.M. Owen, D.J. Mangelsdorf, and S.A. Kliewer Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21 Trends Endocrinol. Metab. 26 2015 22 29
23. G. Paxinos, and K.B. Franklin The Mouse Brain in Stereotaxic Coordinates 2004 Gulf Professional Publishing
24. Pinheiro, J., Bates, D., DebRoy, S., and Sarkar, D. (2013). nlme: linear and nonlinear mixed effects models. R package version 3.1-103. (R Foundation for Statistical Computing). http://CRAN.R-project.org/package=nlme.
25. J. Sánchez, A. Palou, and C. Picó Response to carbohydrate and fat refeeding in the expression of genes involved in nutrient partitioning and metabolism: striking effects on fibroblast growth factor-21 induction Endocrinology 150 2009 5341 5350
26. D.A. Sarruf, J.P. Thaler, G.J. Morton, J. German, J.D. Fischer, K. Ogimoto, and M.W. Schwartz Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats Diabetes 59 2010 1817 1824
27. T. Tanaka, J.S. Ngwa, F.J. van Rooij, M.C. Zillikens, M.K. Wojczynski, A.C. Frazier-Wood, D.K. Houston, S. Kanoni, R.N. Lemaitre, J. Luan, and et al. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake Am. J. Clin. Nutr. 97 2013 1395 1402
28. M.G. Tordoff, and A.A. Bachmanov Influence of the number of alcohol and water bottles on murine alcohol intake Alcohol. Clin. Exp. Res. 27 2003 600 606
29. Y. Weng, J.R. Chabot, B. Bernardo, Q. Yan, Y. Zhu, M.B. Brenner, C. Vage, A. Logan, R. Calle, and S. Talukdar Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice PLoS ONE 10 2015 e0119104
30. C. Zhao, Y. Liu, J. Xiao, L. Liu, S. Chen, M. Mohammadi, C.J. McClain, X. Li, and W. Feng FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice J. Lipid Res. 56 2015 1481 1491